Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Nascent Invest in connection with an investment in Pro Test Diagnostics
Mandate

Vinge has advised Nascent Invest in connection with an investment in Pro Test Diagnostics

May 08, 2020 M&A

Vinge has advised Nascent Invest in connection with their investment in Pro Test Diagnostics, which has produced a unique test kit for blood doping.

The current owner Fort Knox Förvaring is participating in the investment round and the total investment amounts to SEK 17 million.

Vinge’s team consisted of, among others, Johan Winnerblad.

Related

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB

 Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Baker Tilly Helsingborg AB, MOORE Allegretto AB and MOORE Ranby AB.
September 18, 2025

Vinge advises Workday, Inc. on its $1.1 billion acquisition of Sana Labs

 Vinge, together with Orrick Herrington & Sutcliffe, has advised Workday, Inc. (NASDAQ: WDAY) (“Workday”) on its acquisition of all shares in Sana Labs AB.
September 16, 2025

Vinge advises on the sale of ArmaTech to Defensor Group

 Vinge has advised on the sale of ArmaTech i Kungsbacka AB (“ArmaTech”) to the newly formed defence group Defensor Group AB (“Defensor”).
September 16, 2025